Skip to main content
OpenTrials
Completed

NCT Number: NCT04008914

Readmission Risk Factors and Heart Failure With Preserved Ejection Fraction

Retrospective review of 492 patient from a small community hospital who did not qualify for participation in the Connect HF study sponsored by DCRI.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Failure Cardiovascular Diseases Heart Diseases Preserved Ejection Fraction

Sex eligibility

All sexes

Study type

Observational

Primary location

Ascension Macomb-Oakland Hospital

Warren, Michigan, 48093, United States

About this study

Retrospective review of adults above the age of 18 with a primary diagnosis of HFpEF between August 2017 and March 2018. Subjects had to fall into one of two classifications (NYHA Class II-IV or ACC/AHA Stage B-D) and had a life expectancy greater than 6 months are included. Individuals with a terminal illness other than HF, prior heart transplant or on a transplant list, or current/ planned left ventricular assist device excluded. The primary objective of this study is to identify risk factors for readmission in patients discharged with a diagnosis of HFpEF.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • History of Heart failure diagnosis admitted for treatment
  • Ejection fraction < 40% by echocardiogram

Exclusion criteria

  • Ejection fraction >40% by echocardiogram
  • Chronic Kidney disease requiring dialysis
  • Terminal illness
  • New onset diagnosis of Heart Failure

Treatment and study plan

retrospective observation

Other

Retrospective review of study patients excluded from the CONNECT- HF trial who were discharged with a diagnosis of HFpEF between August 1, 2017 and March 1, 2018. Readmission rate at 30 and 90 days along with patient demographics and associated comorbidities were analyzed.

Primary outcomes

  1. Readmission Risk Factors and Heart Failure with Preserved Ejection Fraction

    Time frame: August 1, 2017 though March 1, 2018

    Retrospective review to identify risk factors for readmission in patients discharged with a diagnosis of HFpEF.

Sponsors and collaborators

Lead sponsor

Ascension Macomb-Oakland Hospital

Other

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2019
First posted
Jul 5, 2019
Registry last updated
Jul 8, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.